Jasper Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Jasper Therapeutics generated cash of -$52,067,000, which is less than the previous year. Cash used in financing activities reached the amount of $100,971,000 last year. Net change in cash is therefore $48,637,000.
Cash Flow
| 2019 | -1.96M | 0 | 29.12M |
|---|---|---|---|
| 2020 | -18.26M | 198.34K | 11.28M |
| 2021 | -33.67M | -2.42M | 100.96M |
| 2022 | -45.85M | -576K | 55K |
| 2023 | -52.06M | -267K | 100.97M |
JSPRW Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 38.66M | 85.04M | 20.18M | 27.16M | 4 |
Operating activities | |||||
Net income | -64.46M | -37.68M | -30.63M | -31.66M | -4.98M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 1.10M | 975K | 377K | 21K | 0 |
Stock-based compensation expense | 5.21M | 4.09M | 1.04M | 1.21M | 6K |
| Deferred income tax benefit | 5.21M | 4.09M | 1.04M | 1.21M | 6K |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 663K | -663K | 600K | 0 | 0 |
Inventories | 0 | 663K | -600K | 0 | 0 |
Accounts payable | 2.38M | -2.15M | 2.93M | 358K | 0 |
Cash generated by operating activities | -52.06M | -45.85M | -33.67M | -18.26M | -1.96M |
Investing activities | |||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -267K | -576K | -2.42M | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -267K | -576K | -2.42M | 198.34K | 0 |
Financing activities | |||||
Common Stock Issued | 101.47M | 55K | 10.75M | 11.28M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 28K | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 1.5M |
Cash used in financing activities | 100.97M | 55K | 100.96M | 11.28M | 29.12M |
Net Change In Cash | 48.63M | -46.37M | 64.86M | -6.98M | 27.16M |
Cash at end of period | 87.30M | 38.66M | 85.04M | 20.18M | 27.16M |
| Data source | Data source | Data source | Data source | Data source |